Product Images Carbidopa And Levodopa

This is a description for a medical tablet containing Carbidopa and Levodopa, used to treat the symptoms of Parkinson's disease. The tablet should be swallowed without crushing or chewing and stored in a tightly closed container away from light and moisture. This tablet is manufactured by Alembic Pharmaceuticals Ltd and can be dispensed with a prescription. The package contains 30 tablets, and the National Drug Code is 46708-332-30. The text also includes information on dosage, storage conditions, and manufacturing details.*

This is a medication description for Carbidopa and Levodopa Extended-Release Tablets, USP. Each tablet contains 50 mg of carbidopa and 200 mg of levodopa. The appropriate adult dosage is outlined in the package insert. Tablets should be swallowed without chewing or crushing. The medication should be stored in a closed container, protected from light and moisture, at temperatures ranging from 15°C to 30°C (59°F to 86°F). The manufacturer is Alembic Pharmaceuticals Limited. The medication is dispensed in a tightly closed, light-resistant container. The NDC number is 46708-333-30. It is only available by prescription. No information was provided regarding the medication's indications.*

This appears to be a chemical formula or equation. It includes the compound CHCHCOOH and the compound NH2, but without any additional information or context it is not possible to provide a useful description or interpretation.*